share_log

圣诺医药-B(02257)：戴晓畅辞任首席战略官

Shengnuo Pharmaceutical-B (02257): Dai Xiaochang resigns as Chief Strategy Officer

Zhitong Finance ·  May 17 22:27

Shengnuo Pharmaceutical-B (02257) issued an announcement. Dai Xiaochang has resigned as the Group's Chief Strategy Officer due to personal reasons, since 2...

Zhitong Finance App News, Shengnuo Pharmaceutical-B (02257) issued an announcement. Dai Xiaochang resigned as Group Chief Strategy Officer due to personal reasons, effective May 17, 2024. Dr. Dai will continue as Executive Director and has agreed to serve as the Group's senior advisor for drug development and commercialization.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment